DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB), a specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced that its President and Chief Executive Officer, Dr. Mark Pykett, will participate in an industry panel discussion on companion diagnostics development on Tuesday, February 14, 2012 at 10:30 AM EST as part of the 14th Annual BIO CEO Conference at the Waldorf-Astoria in New York City.
